Skadden advised Theravance Biopharma, while Goodwin Procter advised Royalty Pharma on the deal. Willkie Farr & Gallagher advised Innoviva on the sale of its stake in...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here